Imago Biosciences Inc (IMGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -42,311 | -17,833 | -10,902 | N/A |
| Depreciation Amortization | 115 | 7 | -7 | N/A |
| Accounts payable and accrued liabilities | 2,062 | 8 | 586 | N/A |
| Other Working Capital | 208 | 672 | 271 | N/A |
| Other Operating Activity | 163 | 204 | 44 | 0 |
| Operating Cash Flow | $-39,763 | $-16,942 | $-10,008 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | N/A | -9 | N/A | N/A |
| Purchase Of Investment | -208,422 | -81,083 | -2,728 | N/A |
| Sale Of Investment | 79,153 | 6,750 | N/A | N/A |
| Investing Cash Flow | $-129,269 | $-74,342 | $-2,728 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 164,247 | 29 | N/A | N/A |
| Other Financing Activity | -3,255 | 105,560 | 16,439 | 0 |
| Financing Cash Flow | $160,992 | $105,589 | $16,439 | $N/A |
| Beginning Cash Position | 19,266 | 4,961 | 1,258 | N/A |
| End Cash Position | 11,226 | 19,266 | 4,961 | N/A |
| Net Cash Flow | $-8,040 | $14,305 | $3,703 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -39,763 | -16,942 | -10,008 | N/A |
| Capital Expenditure | N/A | -9 | N/A | N/A |
| Free Cash Flow | -39,763 | -16,951 | -10,008 | 0 |